Puma Biotechnology Inc reports results for the quarter ended in December - Earnings Summary

Puma Biotechnology

03/03/2022 23:45

* Puma Biotechnology Inc  PBYI.OQ  reported quarterly
adjusted
earnings of 10 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 9 cents per share.
    * Revenue rose 5.3% to $55.40 million from a year ago; 
analysts
expected $47.17 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
10
cents​.
    * The mean earnings estimate of analysts had risen by
about 33.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Puma Biotechnology Inc shares had fallen by 27.0% this
quarter.
    * The company reported quarterly net income of $4.2 million.
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $6.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 3 "sell" or "strong sell." 

This summary was machine generated March 3 at 11:45 p.m.  ​All
figures in US dollars unless otherwise stated